Get Cash Back and $0 Commissions + The Power of TradeStation
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Alnylam, Acadia, and India Globalization and Encourages Investors to Contact the Firm
Globe Newswire 5-Nov-2018 6:51 PM
NEW YORK, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Alnylam Pharmaceuticals, Inc., Acadia Healthcare Company, Inc., and India Globalization Capital, Inc. Stockholders have until the deadlines listed below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Class Period: February 15, 2018 - September 12, 2018
Lead Plaintiff Deadline: November 26, 2018
The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements regarding the company's business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) Alnylam overstated the efficacy and safety of its Onpattro (patisiran) lipid complex injection; and (2) as a result, Alnylam's public statements were materially false and misleading at all relevant times.
Class Period: February 23, 2017 - October 24, 2017
Lead Plaintiff Deadline: December 3, 2018
The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements regarding Acadia's business and operations, including by falsely stating that the quality of Acadia's U.K. operations gave it a competitive strength that would drive future growth and profitability, and by issuing false and misleading guidance regarding the company's actual and projected 2017 revenue, earnings before interest, taxes, depreciation and amortization and earnings per share.
India Globalization Capital, Inc. (NYSE:IGC, OTC:IGCC)
Class Period: June 21, 2018 - October 29, 2018
Lead Plaintiff Deadline: January 2, 2019
The complaint filed in this class action alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) India Globalization's business model was in a state of change in order to lure potential blockchain and cannabis investors; (2) India Globalization had overstated the benefits of its relationships with manufacturers, partners, and distributors in order to inflate its potential commercial success in the blockchain and cannabis markets; (3) as a result, the New York Stock Exchange delisted India Globalization's shares from its exchange; and (4) consequently, defendants' statements about India Globalization's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the India Globalization class action go to: http://bespc.com/igc/.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
